12 research outputs found
Efficient Conversion of Light Cycle Oil into High-Octane-Number Gasoline and Light Olefins over a Mesoporous ZSM‑5 Catalyst
Producing
high-octane-number (ON) gasoline and light olefins is a promising
route to valorize light cycle oil (LCO). In this work, the LCO was
mildly hydrogenated and then catalytically cracked to produce high-ON
gasoline and light olefins. Mesoporous ZSM-5 zeolite (meso-ZSM-5)
was prepared and, for the first time, was applied in this process
to crack the hydrogenated LCO (hydro-LCO). The catalytic performance
of meso-ZSM-5 was evaluated in detail under different reaction temperatures
and weight hourly space velocities (WHSVs). The results showed that,
in comparison to less than 64 wt % hydro-LCO conversion over the conventional
ZSM-5 catalyst, the novel catalyst exhibited excellent performance
in cracking hydro-LCO with quite a high conversion of 84.8 wt %, affording
a gasoline yield of 56.4 wt % and light olefin yield of 19.3 wt %
at 560 °C and 10 h<sup>–1</sup>. In addition, the conversion
behaviors of hydro-LCO components were analyzed over both the conventional
ZSM-5 and meso-ZSM-5 catalysts. Finally, on the basis of the study
of the acid and pore properties of both catalysts, a detailed intrinsic
reason for enhanced performance was elucidated. It demonstrated that
the remarkable catalytic performance of the meso-ZSM-5 catalyst was
closely related to the high diffusion of reactants and the accessibility
of acid sites
Mechanistic Insights into the Pore Confinement Effect on Bimolecular and Monomolecular Cracking Mechanisms of <i>N</i>‑Octane over HY and HZSM‑5 Zeolites: A DFT Study
Bimolecular and monomolecular
cracking mechanisms of alkanes simultaneously
occur and have a competitive relationship, which strongly influences
the product distribution. In this work, the density functional theory
(DFT) calculation is first carried out to elucidate two cracking mechanisms
in HZSM-5 and HY zeolites. It is found that the overall apparent reaction
barrier for the monomolecular cracking reaction at 750 K in the HZSM-5
zeolite is 5.30 kcal/mol, much lower than that (23.12 kcal/mol) for
bimolecular cracking reaction, indicating that the monomolecular mechanism
is predominant in the HZSM-5 zeolite. In contrast, the bimolecular
mechanism is predominant in the HY zeolite because of a lower apparent
reaction barrier energy barrier (6.95 kcal/mol) for bimolecular cracking
reaction than that (24.34 kcal/mol) for the monomolecular cracking
reaction. Moreover, the intrinsic reason for the different mechanisms
is further elucidated. The confinement effect can effectively decrease
the energy barrier when the size of transition states is comparable
to the pore size of zeolite. The insights in this work will be of
great significance to the understanding of confinement on catalytic
cracking mechanism and to the design of highly efficient cracking
catalysts
Structure and Composition Changes of Nitrogen Compounds during the Catalytic Cracking Process and Their Deactivating Effect on Catalysts
The comprehensive
structure and composition changes of the nitrogen
compounds during the catalytic cracking processes of coker gas oil
and vacuum residue are investigated using electrospray ionization
combined with Fourier transform ion cyclotron resonance mass spectrometry.
These experiments were conducted over different cracking materials
under the reaction temperatures of 500/520 °C, the weight hourly
space velocity of 18 h<sup>–1</sup>, and the catalyst/oil ratio
of 5. The results show that the diffusion resistance in the micropores
of the zeolite is the key factor affecting the interaction between
the nitrogen compounds and the acid sites. The basic N1 and N2 class
species with double bond equivalence (DBE) values smaller than 10
can easily diffuse into the micropores of the zeolite and are preferentially
adsorbed onto the acid sites. These adsorbed nitrogen compounds generally
conduct condensation reactions and hydrogen transfer reactions to
form coke deposited on the cracking catalysts. The basic N1 and N2
class species with DBE values larger than 10, other basic nitrogen
compounds other than N1 and N2, and the non-basic nitrogen compounds
seldom interact with the acid sites of the zeolite. They usually undergo
side chain thermal cracking on the surface of the matrix, which can
reduce their carbon numbers but cannot change their DBE values. The
basic N1 class species with DBE values smaller than 10 are the main
compounds that poison the cracking catalysts. In comparison to the
SL-CGO catalytic cracking, the nitrogen-poisoning effect on the catalysts
is much less during the SL-VR catalytic cracking process because the
main poisoning compounds (the basic N1 class species with DBE values
smaller than 10) are much fewer
Enhancing the Selectivity of Enzyme Detection by Using Tailor-Made Nanoparticles
Development
of effective ways to specifically and reversibly block
the activity of an enzyme is highly desirable for enhancing the selectivity
of enzyme assays. Here we demonstrate a novel approach for selective
detection of enzyme activities in complex biological samples by using
tailor-made nanoparticles. Employing deoxyribonuclease I (DNase I)
as a model enzyme template, we prepared surface imprinted polymers
over magnetic nanoparticles with monomers screened out of commonly
used functional monomers. The resultant Fe<sub>3</sub>O<sub>4</sub>@MIP nanoparticles can not only block the activity of the target
enzyme via selective adsorption but also quantitatively release the
bound enzyme under mild conditions with the assistance of metal ion
cofactors, which offers a very useful tool for enhancing the selectivity
in enzyme detection. The approach enables sequential detection of
the activities of 3′-5′ exonuclease and DNase I in cell
lysates. The strategy may be further extended to the detection of
other enzyme proteins
Table1_Weekly earthquake prediction in a region of China based on an intensive precursor network AETA.XLSX
Once a majority of earthquakes occur without prediction, it is very likely to have a huge impact on human society. To solve the worldwide challenging problem of earthquake prediction, our laboratory has developed a set of sensory systems to monitor the abnormal activity of geological signals before an earthquake happens in China. At present, more than 300 stations have been deployed, and the observation time has exceeded 4Â years. Based on the various geological activities collected, a local correlation tracking method is used to capture signal anomalies before an earthquake, and then the ROC curve is used for the evaluation of the predictive accuracy. The method is applied in the Sichuan-Yunnan area weekly, verifying the forecast within a 91-week time frame and a 30-week time frame. The method proposed in this article has earthquake prediction ability with a rate of over 70%. It promotes and contributes to helping people avoid the fear of unpredictable earthquakes.</p
Table_4_High Plasma Exposure of Statins Associated With Increased Risk of Contrast-Induced Acute Kidney Injury in Chinese Patients With Coronary Artery Disease.DOCX
<p>The role of statins in reducing the incidence of contrast-induced acute kidney injury (CI-AKI) remains controversial. We sought to evaluate the association between CI-AKI and high plasma exposure of statins in coronary artery disease (CAD) patients undergoing coronary angiography (CAG). This association was first evaluated in 1,219 patients with CAD receiving atorvastatin (AT) therapy and validated in 635 patients receiving rosuvastatin (RST) therapy. The plasma concentrations of statins were quantified using validated UPLC-MS/MS methods and CI-AKI incidence was assessed during the first 48 h postoperatively. Among all participants (n = 1,854), AKI occurred in 57 of 1219 (4.7%) in the AT cohort and 30 of 635 (4.7%) in the RST cohort. High plasma AT-all exposure was associated with increased risk of CI-AKI (odds ratio [OR]: 2.265; 95% confidence interval [CI]: 1.609–3.187; p < 0.0001). Plasma AT-all concentration in the CI-AKI group (22.40 ± 24.63 ng/mL) was 2.6-fold higher than that in the control group (8.60 ± 9.65 ng/mL). High plasma RST exposure also significantly increased the risk of CI-AKI (OR: 2.281; 95% CI: 1.441–3.612; p = 0.0004). We further divided patients into two subgroups for each statin according to baseline renal function, and association between high plasma statin exposure and CI-AKI still remained highly significant in both subgroups. This study suggests for the first time that high plasma exposure of statins may significantly increase the risk of CI-AKI. Statins should be used with greater caution in CAD patients undergoing CAG to reduce the occurrence of CI-AKI.</p
Table_2_High Plasma Exposure of Statins Associated With Increased Risk of Contrast-Induced Acute Kidney Injury in Chinese Patients With Coronary Artery Disease.DOCX
<p>The role of statins in reducing the incidence of contrast-induced acute kidney injury (CI-AKI) remains controversial. We sought to evaluate the association between CI-AKI and high plasma exposure of statins in coronary artery disease (CAD) patients undergoing coronary angiography (CAG). This association was first evaluated in 1,219 patients with CAD receiving atorvastatin (AT) therapy and validated in 635 patients receiving rosuvastatin (RST) therapy. The plasma concentrations of statins were quantified using validated UPLC-MS/MS methods and CI-AKI incidence was assessed during the first 48 h postoperatively. Among all participants (n = 1,854), AKI occurred in 57 of 1219 (4.7%) in the AT cohort and 30 of 635 (4.7%) in the RST cohort. High plasma AT-all exposure was associated with increased risk of CI-AKI (odds ratio [OR]: 2.265; 95% confidence interval [CI]: 1.609–3.187; p < 0.0001). Plasma AT-all concentration in the CI-AKI group (22.40 ± 24.63 ng/mL) was 2.6-fold higher than that in the control group (8.60 ± 9.65 ng/mL). High plasma RST exposure also significantly increased the risk of CI-AKI (OR: 2.281; 95% CI: 1.441–3.612; p = 0.0004). We further divided patients into two subgroups for each statin according to baseline renal function, and association between high plasma statin exposure and CI-AKI still remained highly significant in both subgroups. This study suggests for the first time that high plasma exposure of statins may significantly increase the risk of CI-AKI. Statins should be used with greater caution in CAD patients undergoing CAG to reduce the occurrence of CI-AKI.</p
Table_1_High Plasma Exposure of Statins Associated With Increased Risk of Contrast-Induced Acute Kidney Injury in Chinese Patients With Coronary Artery Disease.DOCX
<p>The role of statins in reducing the incidence of contrast-induced acute kidney injury (CI-AKI) remains controversial. We sought to evaluate the association between CI-AKI and high plasma exposure of statins in coronary artery disease (CAD) patients undergoing coronary angiography (CAG). This association was first evaluated in 1,219 patients with CAD receiving atorvastatin (AT) therapy and validated in 635 patients receiving rosuvastatin (RST) therapy. The plasma concentrations of statins were quantified using validated UPLC-MS/MS methods and CI-AKI incidence was assessed during the first 48 h postoperatively. Among all participants (n = 1,854), AKI occurred in 57 of 1219 (4.7%) in the AT cohort and 30 of 635 (4.7%) in the RST cohort. High plasma AT-all exposure was associated with increased risk of CI-AKI (odds ratio [OR]: 2.265; 95% confidence interval [CI]: 1.609–3.187; p < 0.0001). Plasma AT-all concentration in the CI-AKI group (22.40 ± 24.63 ng/mL) was 2.6-fold higher than that in the control group (8.60 ± 9.65 ng/mL). High plasma RST exposure also significantly increased the risk of CI-AKI (OR: 2.281; 95% CI: 1.441–3.612; p = 0.0004). We further divided patients into two subgroups for each statin according to baseline renal function, and association between high plasma statin exposure and CI-AKI still remained highly significant in both subgroups. This study suggests for the first time that high plasma exposure of statins may significantly increase the risk of CI-AKI. Statins should be used with greater caution in CAD patients undergoing CAG to reduce the occurrence of CI-AKI.</p
Table_3_High Plasma Exposure of Statins Associated With Increased Risk of Contrast-Induced Acute Kidney Injury in Chinese Patients With Coronary Artery Disease.DOCX
<p>The role of statins in reducing the incidence of contrast-induced acute kidney injury (CI-AKI) remains controversial. We sought to evaluate the association between CI-AKI and high plasma exposure of statins in coronary artery disease (CAD) patients undergoing coronary angiography (CAG). This association was first evaluated in 1,219 patients with CAD receiving atorvastatin (AT) therapy and validated in 635 patients receiving rosuvastatin (RST) therapy. The plasma concentrations of statins were quantified using validated UPLC-MS/MS methods and CI-AKI incidence was assessed during the first 48 h postoperatively. Among all participants (n = 1,854), AKI occurred in 57 of 1219 (4.7%) in the AT cohort and 30 of 635 (4.7%) in the RST cohort. High plasma AT-all exposure was associated with increased risk of CI-AKI (odds ratio [OR]: 2.265; 95% confidence interval [CI]: 1.609–3.187; p < 0.0001). Plasma AT-all concentration in the CI-AKI group (22.40 ± 24.63 ng/mL) was 2.6-fold higher than that in the control group (8.60 ± 9.65 ng/mL). High plasma RST exposure also significantly increased the risk of CI-AKI (OR: 2.281; 95% CI: 1.441–3.612; p = 0.0004). We further divided patients into two subgroups for each statin according to baseline renal function, and association between high plasma statin exposure and CI-AKI still remained highly significant in both subgroups. This study suggests for the first time that high plasma exposure of statins may significantly increase the risk of CI-AKI. Statins should be used with greater caution in CAD patients undergoing CAG to reduce the occurrence of CI-AKI.</p